Zeo ScientifiX (ZEOX) Other Non Operating Income (2017 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Other Non Operating Income of $5000.0 for Q2 2026, up 66.67% year-over-year from $3000.0 in Q2 2025, and down 70.59% quarter-over-quarter from $17000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Other Non Operating Income (2017 - 2026) Analysis & Trends
Zeo ScientifiX's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $5000.0 for Q2 2026.
- In Q2 2026, Other Non Operating Income rose 66.67% year-over-year to $5000.0; the TTM figure through Apr 2026 stood at $57000.0 (up 61.1% YoY), while the FY2025 annual figure was $101000.0, down 86.55% from the prior year.
- Other Non Operating Income for Q2 2026 stood at $5000.0, down from $17000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $32000.0 in Q1 2025, with the low at $3000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5,000.00 |
| Jan 31, 2026 | 17,000.00 |
| Apr 30, 2025 | 3,000.00 |
| Jan 31, 2025 | 32,000.00 |
| Oct 31, 2021 | 381.00 |
| Jul 31, 2021 | 3,522.00 |
| Apr 30, 2021 | 10.00 |
| Jan 31, 2021 | 21,565.00 |
| Oct 31, 2020 | 15,360.00 |
| Jul 31, 2020 | 300.00 |
| Apr 30, 2020 | 1,200.00 |
| Jan 31, 2020 | 15,857.00 |
| Oct 31, 2019 | 3,327.00 |
| Jul 31, 2019 | 609.00 |
| Apr 30, 2019 | 28,072.00 |
| Jan 31, 2019 | 52,781.00 |
| Oct 31, 2018 | 41,894.00 |
| Jul 31, 2018 | -69.00 |
| Apr 30, 2018 | 20,529.00 |
| Oct 31, 2017 | 14,835.00 |